This study further found that the predominant cell type expressing PD-L1 in breast cancer is not tumor cells but macrophages and dendritic cells, whereas high expression of PD-L1 on macrophages and dendritic cells was predictive of immunotherapy response. This evidence concerns the gene CD274 and breast carcinoma.